Marco DiBlasi

Mr. Marco DiBlasi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Infection and Immunity
Verified
Journal Article
Open access
MSMohammad Omar Faruk Shaikh
Mohammad Omar Faruk Shaikh
MSMatthew M. Schaefers
Matthew M. Schaefers
CMChristina Merakou
Christina Merakou
MDMarco DiBlasi
Marco DiBlasi
SBSarah Bonney
Sarah Bonney
GPGregory P. Priebe
Gregory P. Priebe
The Gram-negative pathogen Pseudomonas aeruginosa is a common cause of pneumonia in hospitalized patients. Its increasing antibiotic resistance and widespread occurrence present a pressing need for vaccines.

13 November 2024 in Radiology Case Reports
Verified
Journal Article
Open access
KTKaleb Taylor
Kaleb Taylor
MDMarco DiBlasi
Marco DiBlasi
EPErik Pedersen
Erik Pedersen
NSNastaran Shahsavari
Nastaran Shahsavari
Juvenile nasopharyngeal angiofibroma (JNA) is a rare, locally aggressive, highly vascularized benign tumor classically found in males from 13 to 20 years old. The most common clinical presentations are recurrent epistaxis and nasal congestion. Imaging plays a significant role in differentiating and determining the extension of nasopharyngeal lesions. The case below highlights a 15-year-old male that presented with nasal congestion and recurrent epistaxis, who underwent nasal endoscopy and ablation. Persisting symptoms led to further evaluation by computed tomography and magnetic resonance imaging of the head; thus, the patient was diagnosed with JNA. Subsequently, the patient underwent angiographic embolization of the maxillary artery branches and eventually, endoscopic tumor resection. The presenting case is an example for physicians that might encounter an unsuspecting case of JNA to expedite diagnosis and care.

9 January 2022 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
MDMarco DiBlasi
Marco DiBlasi
CJChristopher Jayne
Christopher Jayne
RMReilly McNamara
Reilly McNamara
CICatherine Iasiello
Catherine Iasiello
DCDaryl Colden
Daryl Colden
Plasmablastic lymphoma (PBL) is an aggressive, rare variant of B-cell lymphoma typically associated with human immunodeficiency virus and other immunocompromised populations. Most commonly found in the oral cavity, PBL can occasionally originate in the sinonasal tract. Diagnosis of PBL is difficult due to overlapping features with other malignancies; however, early detection and treatment are imperative given its aggressive clinical course. When in the sinonasal tract, the diagnostic process can be further complicated if the patient has a history of recurrent nasal polyposis. Described is the case of a 57-year-old immunocompetent male who initially presented with benign nasal polyposis, only to return a year after sinus surgery with a unilateral sinonasal mass consistent with PBL. As literature has yet to characterize this phenomenon, this article presents the first case reported of sinonasal PBL arising in the setting of recurrent nasal polyposis. This case emphasizes the importance of investigating sinonasal masses showing laterality, maintaining a high index of suspicion for malignancy, and keeping close surveillance of the patient after treatment of PBL.

18 October 2025 in Cancer Epidemiology
Verified
Journal Article
Closed access
SRSebastian Respicio
Sebastian Respicio
DRDaniel Ryan
Daniel Ryan
CBChristopher Bine
Christopher Bine
SZStone Zhang
Stone Zhang
PSPeter Silberstein
Peter Silberstein
MDMarco DiBlasi
Marco DiBlasi

5 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMohammad Omar Faruk Shaikh
Mohammad Omar Faruk Shaikh
MSMatthew M. Schaefers
Matthew M. Schaefers
CMChristina Merakou
Christina Merakou
MDMarco DiBlasi
Marco DiBlasi
SBSarah Bonney
Sarah Bonney
GPGregory P. Priebe
Gregory P. Priebe
The Gram-negative pathogen Pseudomonas aeruginosa is a common cause of pneumonia in hospitalized patients. Its increasing antibiotic resistance and widespread occurrence present a pressing need for vaccines. We previously showed that a P. aeruginosa type III secretion system protein, PopB elicits a strong Th17 response in mice after intranasal (IN) immunization and confers antibody-independent protection against pneumonia in mice. In the current study, we evaluated the immunogenicity and protective efficacy in mice of the combination of PopB (purified with its chaperone protein PcrH) and OprF/I, an outer membrane hybrid fusion protein, compared to immunization with the proteins individually either by the intranasal (IN) or subcutaneous (SC) routes. Our results show that after vaccination, a Th17 recall response from splenocytes was detected only in mice vaccinated with PopB/PcrH, either alone or in combination with OprF/I. Mice that were immunized with the combination of PopB/PcrH and OprF/I had enhanced protection in an acute lethal P. aeruginosa pneumonia model, regardless of vaccine route, compared to the mice vaccinated the with either alone or adjuvant control. Immunization generated IgG titers against the vaccine proteins and whole P. aeruginosa cells. Interestingly, none of these antisera had opsonophagocytic killing activity, but antisera from mice immunized with vaccines containing OprF/I had the ability to block IFN-γ binding to OprF/I, a known virulence mechanism. Hence, vaccines combining PopB/PcrH with OprF/I that elicit functional antibodies lead to a broadly and potently protective vaccine against P. aeruginosa pulmonary infections.

5 February 2024 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MMMariel Manzor
Mariel Manzor
SKSophia Koutsogiannaki
Sophia Koutsogiannaki
MDMarco DiBlasi
Marco DiBlasi
MSMatthew Schaefers
Matthew Schaefers
GPGregory Priebe
Gregory Priebe
KYKoichi Yuki
Koichi Yuki
Cystic fibrosis (CF) is a genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) that controls chloride current. A number of different CFTR transgenic mouse lines have been developed and subjected to both acute and chronic infection models. However, prior studies showed no substantial differences in bacterial clearance between CF and non-CF mice after single inoculations. Here, using F508del transgenic CF mice, we examined the role of repeated acute Pseudomonas aeruginosa (PA) infection, with the second inoculation 7 days after the first. We found that CF mice were more susceptible to PA infection than non-CF mice following the second inoculation, with non-CF mice showing better neutrophil recruitment and effector functions. We further investigated the characteristics of lung immune cells using single-cell RNA sequencing, finding that non-CF lung neutrophils had more prominent upregulation of adhesion molecules including intercellular adhesion molecule-1 (ICAM-1) compared to CF lung neutrophils. Although people with CF are often colonized with bacteria and have high numbers of neutrophils in the airways during chronic infection, these data suggest that CF neutrophils have deficient effector functions in the setting of repeated acute infection.